oxazoles has been researched along with Peripheral Nerve Diseases in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ardizzone, A; Campolo, M; Casili, G; Cuzzocrea, S; Esposito, E; Filippone, A; Lanza, M; Mare, M; Memeo, L; Paterniti, I; Puglisi, C; Scuderi, SA | 1 |
| Audano, M; Azcoitia, I; Carozzi, V; Caruso, D; Cavaletti, G; Cermenati, G; Crestani, M; D'Antonio, M; De Fabiani, E; Ferri, C; Garcia-Segura, LM; Giatti, S; Melcangi, RC; Mitro, N; Pettinato, E; Porretta-Serapiglia, C; Saez, E; Scurati, S | 1 |
2 other study(ies) available for oxazoles and Peripheral Nerve Diseases
| Article | Year |
|---|---|
PEA-OXA Mitigates Oxaliplatin-Induced Painful Neuropathy through NF-κB/Nrf-2 Axis.
Topics: Animals; Disease Models, Animal; Ganglia, Spinal; Humans; Mice; Neoplasms; NF-E2-Related Factor 2; NF-kappa B; Oxaliplatin; Oxazoles; Pain; Peripheral Nervous System Diseases; Rats; Signal Transduction | 2021 |
Lack of sterol regulatory element binding factor-1c imposes glial Fatty Acid utilization leading to peripheral neuropathy.
Topics: Analysis of Variance; Animals; Blotting, Western; Chromatography, High Pressure Liquid; Fatty Acids; Metabolomics; Mice; Mice, Knockout; Microarray Analysis; Microscopy, Electron, Transmission; Myelin Sheath; Neuroglia; Oxazoles; Peripheral Nervous System Diseases; PPAR alpha; Real-Time Polymerase Chain Reaction; Sterol Regulatory Element Binding Protein 1; Tyrosine | 2015 |